Wyoming Jail Launches First Medication Assisted Treatment Program

Wyoming’s first medication-assisted treatment program inside a county jail is now operating at the Sheridan County Detention Center, a milestone that addiction medicine specialists say could improve both withdrawal safety and long-term recovery outcomes for incarcerated people across the state.

For people dependent on opioids, being jailed without access to medication-assisted treatment doesn’t just cause suffering, it can be life-threatening.

The launch of this program marks a significant shift in how Wyoming approaches opioid dependence behind bars.

Why Medication-Assisted Treatment in Jails Matters

Jails and detention centers have historically been among the most dangerous settings for people with opioid use disorder.

When someone dependent on opioids is suddenly incarcerated, they face abrupt, unmanaged withdrawal, a process that is intensely painful and, in certain circumstances, medically serious.

Beyond the immediate withdrawal period, forced abstinence in jail dramatically lowers a person’s opioid tolerance. Upon release, if that person returns to using, even a previously tolerated dose can cause a fatal overdose.

This is why medication-assisted treatment, the use of FDA-approved medications like buprenorphine (Suboxone), methadone, or naltrexone to treat opioid use disorder, is considered the gold standard of care by organizations including SAMHSA, the American Society of Addiction Medicine (ASAM), and the National Institutes of Health.

Withholding these medications from incarcerated individuals has increasingly been challenged in federal courts as a violation of the Americans with Disabilities Act.

The Sheridan County program is the first of its kind in Wyoming, a state where access to addiction treatment has historically lagged behind the national average due to rural geography and limited provider networks.

Understanding Buprenorphine and Other MAT Medications

Medication-assisted treatment programs typically rely on one of three medications, each serving a different clinical role.

Buprenorphine (often dispensed as Suboxone, which also contains naloxone) is a partial opioid agonist, meaning it activates opioid receptors enough to prevent withdrawal and cravings without producing the same euphoric effect as full agonists like heroin or prescription opioids.

It is typically prescribed in office-based settings and has been shown to significantly reduce overdose deaths, illicit drug use, and criminal recidivism.

Methadone, a full opioid agonist dispensed daily through federally licensed clinics, is used for patients with more severe opioid dependence or those who have not responded to buprenorphine.

Naltrexone (Vivitrol), an opioid antagonist, blocks opioid receptors entirely. It is non-addictive and has no abuse potential, making it particularly attractive in correctional settings, though it requires full detox before initiation, meaning patients must be completely opioid-free before receiving it.

Jails as a Bridge to Recovery

Programs like the one in Sheridan County represent a growing movement to treat incarceration as an opportunity to initiate treatment, not simply remove substances.

Research consistently shows that people who receive medication-assisted treatment while incarcerated are more likely to continue treatment after release and less likely to relapse or return to custody.

Wyoming’s correctional system has been slower than many states to adopt these programs.

States like Rhode Island, Vermont, and Massachusetts have operated comprehensive MAT programs in correctional facilities for years, with documented reductions in post-release overdose deaths. Wyoming’s move, even at the county jail level, signals a meaningful shift in policy.

For families and individuals researching options, it’s worth understanding the different levels of care in addiction treatment.

ASAM defines a spectrum ranging from outpatient services to Level 4 medically managed intensive inpatient care.

Jail-based MAT programs function as a form of medically supervised withdrawal management and maintenance, bridging patients toward community-based detox programs and ongoing medication-assisted treatment upon release.

Finding Medical Detox in Wyoming

For anyone struggling with opioid dependence outside of a jail setting, medically supervised withdrawal management remains the safest path forward.

Attempting to detox from opioids alone carries serious risks, including severe dehydration, dangerous withdrawal complications, and a dramatically elevated overdose risk if relapse occurs.

Medical detox programs, whether inpatient or outpatient, provide clinical monitoring and access to medication-assisted treatment to manage these risks safely.

Detox.com lists a variety of detox centers across the nation. If you or someone you love needs opioid detox in Wyoming, call 800-996-6135(Sponsored) to find medically supervised detox programs and medication-assisted treatment providers near you.